Susquehanna International Group’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-73,323
Closed -$111K 5733
2024
Q2
$111K Buy
+73,323
New +$111K ﹤0.01% 5059
2024
Q1
Sell
-10,062
Closed -$29.5K 5652
2023
Q4
$29.5K Buy
+10,062
New +$29.5K ﹤0.01% 5622
2023
Q3
Sell
-10,259
Closed -$90K 5625
2023
Q2
$90K Buy
+10,259
New +$90K ﹤0.01% 5045
2023
Q1
Sell
-21,722
Closed -$265K 6044
2022
Q4
$265K Buy
21,722
+1,266
+6% +$15.4K ﹤0.01% 4073
2022
Q3
$174K Buy
20,456
+5,781
+39% +$49.2K ﹤0.01% 4915
2022
Q2
$238K Buy
14,675
+5,567
+61% +$90.3K ﹤0.01% 4315
2022
Q1
$110K Sell
9,108
-23,020
-72% -$278K ﹤0.01% 5110
2021
Q4
$524K Sell
32,128
-2,681
-8% -$43.7K ﹤0.01% 3727
2021
Q3
$552K Sell
34,809
-4,244
-11% -$67.3K ﹤0.01% 3560
2021
Q2
$3.61M Sell
39,053
-349
-0.9% -$32.2K ﹤0.01% 1522
2021
Q1
$2.05M Buy
39,402
+25,397
+181% +$1.32M ﹤0.01% 2087
2020
Q4
$378K Buy
+14,005
New +$378K ﹤0.01% 3681
2020
Q3
Sell
-3,318
Closed -$48K 4457
2020
Q2
$48K Sell
3,318
-33,304
-91% -$482K ﹤0.01% 4033
2020
Q1
$411K Buy
36,622
+4,335
+13% +$48.7K ﹤0.01% 3095
2019
Q4
$672K Buy
32,287
+18,993
+143% +$395K ﹤0.01% 2309
2019
Q3
$311K Buy
13,294
+7,880
+146% +$184K ﹤0.01% 3370
2019
Q2
$162K Buy
5,414
+3,399
+169% +$102K ﹤0.01% 3986
2019
Q1
$42K Buy
+2,015
New +$42K ﹤0.01% 2784
2018
Q4
Sell
-4,214
Closed -$181K 3760
2018
Q3
$181K Buy
4,214
+1,639
+64% +$70.4K ﹤0.01% 2794
2018
Q2
$100K Buy
2,575
+1,830
+246% +$71.1K ﹤0.01% 3288
2018
Q1
$16K Buy
+745
New +$16K ﹤0.01% 3240
2017
Q2
Hold
0
3590
2017
Q1
Sell
-779
Closed -$30K 3357
2016
Q4
$30K Sell
779
-1,048
-57% -$40.4K ﹤0.01% 4026
2016
Q3
$103K Buy
1,827
+494
+37% +$27.9K ﹤0.01% 2700
2016
Q2
$45K Buy
+1,333
New +$45K ﹤0.01% 3011
2016
Q1
Sell
-737
Closed -$44K 3885
2015
Q4
$44K Buy
+737
New +$44K ﹤0.01% 4063
2015
Q3
Sell
-1,981
Closed -$112K 4183
2015
Q2
$112K Buy
+1,981
New +$112K ﹤0.01% 4235